October 22, 2014 — The Cardiovascular Cell Therapy Research Network (CCTRN) has selected Cytori Therapeutics Inc. to ...
Diagnostic and Interventional Cardiology DAIC
Diagnostic and Interventional Cardiology (DAIC) is a magazine that reaches more than 25,000 healthcare professionals in cardiology, interventional cardiology and cath labs across the United States. These influential buying team members rely on DAIC's award-winning editorial content and comparison charts as a unique research tool for specifying, recommending and approving technology/device purchases.
October 22, 2014 — Healthcare organizations looking to implement low dose protocols for computed tomography (CT) exams o ...
Oct. 22, 2014 — Cardiothoracic and Vascular Surgeons became the first in Texas to implant the Solo Smart Aortic ...
October 21, 2014 — A research study published in the July issue of the Journal of the American College of Cardiology rep ...
October 21, 2014 — Infinitt North America will be featuring Dose M 2.0 radiation dose tracking software at this year’s ...
October 21, 2014 — Calgary Scientific Inc. has gained U.S. Food and Drug Administration (FDA) clearance of ResolutionMD ...
October 21, 2014 — Siemens Healthcare has announced that the U.S. Food and Drug Administration (FDA) has cleared the new ...
October 20, 2014 — Sony Electronics’ Medical Systems Division is highlighting four new medical printers at RSNA 2014 ...
October 20, 2014 — Samsung Electronics America Inc. announced the preliminary results of a groundbreaking trial into the ...
October 17, 2014 — Materialise NV has listed its 3-D-printed cardiovascular HeartPrint models as a medical device in U.S ...
Siemens introduces True volume transesophageal echo (TEE) transducer — this 3-D/4-D 90°x90° TEE solution enables ...
October 16, 2014 — Sunshine Heart Inc. today announced the results of its feasibility study entitled “Ambulatory Extra ...
October 16, 2014 — A team of surgeons at New York-Presbyterian/Morgan Stanley Children’s Hospital saved the life of a ...
October 16, 2014 - Neovasc Inc. has received conditional Investigational Device Exemption (IDE) approval from the U.S ...
October 15, 2014 — Novartis Pharmaceuticals Canada Inc. revealed, in the largest heart failure study to date, that its ...
October 22, 2014